Danaher Corporation.
American conglomerate
- Reports this week
- 11
- Active events
- 3
- Connections
- 115
What's happening
Active this week
-
Multiple financial firms and individuals bought new stakes or adjusted holdings in Danaher Corporation on October 18, 2026.Some support1 report
-
Danaher Corporation is the subject of an SEC filing tracking institutional investment activity, alongside a rating issued by Royal Bank of Canada.Well supported6 reports
-
Morgan Stanley lifted its price target and gave an overweight rating, while TD Cowen increased its target price and gave a buy rating for Danaher Corporation.Some support1 report
Earlier this month
One to three months ago
-
Danaher Corporation and Thermo Fisher Scientific Inc. are competing in the life sciences tools market.Some support2 reports
-
Agilent Technologies, Inc., Merck’s Keytruda, and Danaher Corporation are involved in the market for companion diagnostics for specific cancers.Some support2 reports
-
Danaher Corporation and Johnson & Johnson are competing in the life sciences and bioprocessing markets.Some support1 report
-
Danaher and Eli Lilly benefit from improving financial fundamentals despite policy uncertainty caused by tariffs and spending cuts.Some support1 report
-
Intuitive Surgical, Danaher Corporation, MarketBeat, and Eli Lilly and Company are featured in MarketBeat's stock screener and operate globally.Some support1 report
-
Fortive originated as a spin-off from Danaher and spun off Vontier in 2020; Fortive is headquartered in Everett, Washington.Some support1 report1 development inside
-
Danaher Corporation received analyst coverage (buy rating) and filed disclosures regarding its share holdings and portfolio value.Some support7 reports1 development inside
Gone quiet
No new reports in 90+ days-
Envista Holdings Corporation, a brand of Nobel Biocare, benefits from Trump-era tariffs and was recently spun off from Danaher Corporation.Some support1 report
-
Norges Bank bought a new position in Danaher shares, and Royal Bank of Canada started coverage with an 'outperform' rating.Some support1 report
-
Danaher Corporation owns Beckman Coulter segments, which has roots in Caltech and operates in Brea, as highlighted by the Business Journal.Some support2 reports
-
MarketBeat featured Danaher, Moderna, and Vertex Pharmaceuticals in its stock screener.Some support23 reports
-
Financial news reports include HSBC cutting price targets on Danaher shares and corporate transactions involving Masimo.Well supported3 reports
-
Danaher Corporation has filed required reports with the SEC, and Morgan Stanley has provided advice regarding price targets.Some support2 reports
-
Danaher Corporation filed ownership data with the SEC.Some support3 reports
-
Danaher Corporation is involved in the analyst rating services market alongside Jefferies Financial Group.Some support1 report
-
Leica Biosystems is a company of Danaher Corporation.Some support1 report
-
Life sciences companies Danaher Corporation and Twist Bioscience are facing headwinds due to exposure to China and academic spending.Some support1 report
-
Norges Bank bought a new position in Danaher Corporation on June 15, 2026.Some support2 reports
-
MarketBeat used its screener to highlight Danaher Corporation's stock on June 14, 2026.Well supported3 reports
-
Danaher Corporation filed disclosures with the SEC and DZ Bank began covering its shares.Some support1 report
-
Danaher Corporation benefits from positive trends in China, while Wells Fargo cut its price target following quarterly results, influenced by Trump-era tariffs.Some support2 reports
-
The IVD market in India is driven by NCDs, with key companies like Roche, Sysmex, Danaher, Qiagen, and Quidel leading innovation-driven growth.Some support1 report
-
Market growth and trade activity involving major companies like Abbott, Roche, Siemens, and Danaher in Africa.Some support1 report
-
Trump pledged to unleash American oil and gas, while Steven Rales reported selling $246m worth of Danaher shares on August 5, 2025.Some support1 report
-
A market report profiled key companies in the oligonucleotide synthesis market, including Danaher, Biogen, AstraZeneca, and others.Speculative1 report
-
Jim Cramer expressed sustained pessimism regarding Danaher Corporation's investment potential.Speculative1 report
-
Greg was appointed Executive Vice President at Danaher on June 27, 2025, overseeing companies including Beckman Coulter, Genedata, and Leica Microsystems, and joining via the acquisition of Molecular Devices.Speculative1 report
-
Danaher Corporation is noted to benefit from Trump-era tariffs, a point recently highlighted by Jim Cramer.Speculative1 report
-
Danaher Corporation reported increased demand for consumables from large pharmaceutical customers in Europe and Southeast Asia.Some support1 report1 development inside
-
The biopharmaceuticals manufacturing consumables testing market is growing, driven by demand for validated products, while US tariffs are simultaneously escalating costs for critical testing consumables.Speculative1 report
-
Danaher Corporation and AstraZeneca formed a partnership to scale precision medicine.Some support1 report
-
Scotiabank analysts and TipRanks show strong buy consensus for life science tools, including Danaher Corporation.Some support1 report
-
Leadership changes at Danaher Corporation, including Matthew McGrew's retirement, Gugino's transition to CFO, and Rainer Blair becoming President and CEO.Some support1 report
-
Danaher Corporation reported its segment revenues for the Life Sciences, Diagnostics, and Biotechnology divisions on July 22, 2025.Some support1 report
-
Danaher's stock is analyzed using momentum investing principles.Some support1 report
-
LabCorp and Quest Diagnostics are notable players in the market alongside Danaher Corporation.Some support1 report1 development inside
-
Aldevron, a company owned by Danaher, is expanding into the Boston biotech corridor.Some support1 report
-
Danaher acquired companies including Cepheid and Cytiva during a corporate transformation, appointing individuals like Jonathan Leiken and Brian Ellis to key roles.Some support4 reports
-
Veralto Corporation, which spun off from Danaher in 2023, operates globally and includes PQI in its segments.Some support5 reports
-
Zacks Investment Research provided stock analysis and recommendations for Danaher Corporation on August 18, 2025.Some support1 report
-
Danaher's fund performance was compared against the S&P 500 Index on August 22, 2025.Some support2 reports
-
Danaher Corporation expanded its Life Sciences segment through an acquisition, coinciding with increased demand for consumables in Europe.Some support1 report1 development inside
-
Envista Holdings Corporation was formed as a wholly-owned subsidiary of Danaher Corporation on August 26, 2025.Some support3 reports
-
Danaher Corporation is headquartered in the District of Columbia and markets products across the United States.Well supported3 reports
-
Danaher, Thermo Fisher Scientific, and Agilent Technologies are focused on dominating the global PFAS Testing market.Some support1 report
-
Danaher Corporation provides bioprocess technologies and manufacturing services while Q32 Bio Inc. develops biologic therapeutics for autoimmune diseases.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Danaher Corporation this week
News at the entities that move Danaher Corporation most-
Masimo StructuralFDA granted 510(k) clearance to Masimo for its AFib monitoring capability.Moves Danaher Corporation
-
SEC StructuralLaser Photonics Corporation hired Tim Peterman as Chief Financial Officer and engaged CBIZ for financial reporting consulting.Moves Danaher Corporation
-
Securities and Exchange Commission StructuralNYSE and Nasdaq plan to expand trading hours and file updated rules with the SEC.Moves Danaher Corporation
-
TD Cowen Mentioned togetherTD Cowen upgraded Maze Therapeutics shares to a strong-buy rating, with coverage reported by MarketBeat.Moves Danaher Corporation
-
FDA StructuralNeurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.Moves Danaher Corporation
-
Jim Cramer OperationalJim Cramer warns about yield affecting Microsoft and Nvidia shareholders as rate pressure impacts tech infrastructure costs.Moves Danaher Corporation
Connections
The 40 strongest of 115, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Leica Biosystems Structural
Leica Biosystems is a subsidiary of Danaher Corporation.
-
Masimo Structural
Danaher Corporation is the parent company of Masimo, having acquired it as a wholly owned subsidiary.
-
AB Sciex Structural
Danaher Corporation is the operating company and parent entity of AB Sciex.
-
Securities and Exchange Commission Structural
Danaher Corporation is subject to mandatory regulatory oversight and reporting requirements by the Securities and Exchange Commission.
-
Beckman Coulter Structural
Danaher Corporation owns segments of Beckman Coulter, integrating them into its diagnostics portfolio.
-
Thermo Fisher Scientific Inc. Operational
The two companies are direct competitors in specialized life sciences markets, including oligonucleotide synthesis, PFAS testing, and life sciences tools.
-
SEC Structural
Danaher Corporation is subject to formal regulatory oversight by the SEC, requiring mandatory disclosures regarding its financial activities and holdings.
-
Abcam Structural
Danaher Corporation acquired Abcam, establishing Abcam as a subsidiary within Danaher's Life Sciences segment.
Show all 40 connections
-
Envista Holdings Corporation Transactional
The relationship culminated in a corporate spin-off of Envista Holdings Corporation from Danaher Corporation.
-
Cepheid Structural
Danaher acquired Cepheid, integrating it into its diagnostics portfolio as a subsidiary.
-
Boston Scientific Operational
Both companies are leading manufacturers in the medical device industry and actively compete for market share.
-
Fortive Transactional
Fortive originated as a spin-off from Danaher, marking a completed corporate transition.
-
AstraZeneca Operational
Danaher and AstraZeneca maintain a formal partnership focused on developing and scaling precision medicine diagnostics.
-
Jim Cramer Operational
Jim Cramer frequently provides investment commentary and criticism regarding Danaher Corporation.
-
Johnson & Johnson Operational
The two companies are actively competing against each other within the life sciences and bioprocessing markets.
-
Morgan Stanley Operational
Morgan Stanley provides financial ratings and price targets for Danaher Corporation.
-
TD Cowen Mentioned together
TD Cowen provided a buy rating and raised the target price for Danaher Corporation.
-
Nvidia Operational
Danaher and Nvidia are collaborating to combine scientific instruments with AI capabilities.
-
Jefferies Financial Group Operational
Jefferies provides financial ratings and price targets for Danaher stock within the analyst services market.
-
Royal Bank of Canada Mentioned together
Royal Bank of Canada provides financial research notes, ratings, and target price updates on Danaher Corporation stock.
-
China Shared context
Danaher's business performance is influenced by market conditions, demand, and geopolitical factors in China.
-
Norges Bank Transactional
Norges Bank purchased a new financial position/stake in Danaher Corporation shares.
-
FDA Structural
FDA's regulatory approvals dictate the commercial viability and market value of companies in the life sciences sector.
-
MarketBeat Mentioned together
MarketBeat uses its stock screener and tracking tools to report on and highlight Danaher Corporation's stock performance.
-
Merck KGaA Operational
The two companies are active competitors operating within the diagnostic market space.
-
Middle East Shared context
Middle East conflicts drive commodity price changes that influence Danaher Corporation's operational environment.
-
HSBC Transactional
HSBC downgraded its price target for Danaher Corporation shares.
-
Eli Lilly and Company Mentioned together
The evidence suggests the two companies are frequently mentioned together as examples of successful entities benefiting from market conditions.
-
Medtronic plc Mentioned together
Both companies are identified as major players within the healthcare sector.
-
Europe Shared context
Danaher Corporation operates and sees increased demand for consumables within the European market.
-
Caterpillar Inc. Mentioned together
Both companies are grouped together as industrial stocks to monitor, indicating shared market context.
-
Twist Bioscience Operational
The entities are identified as competitors operating within the life sciences sector.
-
District of Columbia Shared context
Danaher Corporation is headquartered in the District of Columbia.
-
AbbVie Mentioned together
Both Danaher Corporation and AbbVie are identified as major players within the biotech sector.
-
Vertex Pharmaceuticals Mentioned together
Both companies are identified as major players within the biotech sector.
-
Stryker Corporation Mentioned together
Danaher and Stryker are grouped thematically as leading medical device manufacturers.
-
Moderna Mentioned together
Both companies are frequently cited together as leading examples of high-growth biotechnology companies in the market.
-
DZ Bank Mentioned together
DZ Bank provides financial coverage and buy ratings for Danaher Corporation.
-
Amgen Shared context
Both companies operate within the highly competitive global biotechnology market.
-
Roper Technologies Operational
Both Danaher Corporation and Roper Technologies are noted for employing an acquisition strategy for growth.
History
Events by the month they beganOctober 2026
3 events- Multiple financial firms and individuals bought new stakes or adjusted holdings in Danaher Corporation on October 18, 2026.
- Danaher Corporation is the subject of an SEC filing tracking institutional investment activity, alongside a rating issued by Royal Bank of Canada.
- Morgan Stanley lifted its price target and gave an overweight rating, while TD Cowen increased its target price and gave a buy rating for Danaher Corporation.
September 2026
2 eventsAugust 2026
2 eventsShow 2 earlier months
July 2026
5 events- Danaher Corporation and Johnson & Johnson are competing in the life sciences and bioprocessing markets.
- Danaher and Eli Lilly benefit from improving financial fundamentals despite policy uncertainty caused by tariffs and spending cuts.
- Intuitive Surgical, Danaher Corporation, MarketBeat, and Eli Lilly and Company are featured in MarketBeat's stock screener and operate globally.
- Envista Holdings Corporation, a brand of Nobel Biocare, benefits from Trump-era tariffs and was recently spun off from Danaher Corporation.
- Norges Bank bought a new position in Danaher shares, and Royal Bank of Canada started coverage with an 'outperform' rating.
June 2026
39 events- Fortive originated as a spin-off from Danaher and spun off Vontier in 2020; Fortive is headquartered in Everett, Washington.
- Danaher Corporation received analyst coverage (buy rating) and filed disclosures regarding its share holdings and portfolio value.
- Danaher Corporation owns Beckman Coulter segments, which has roots in Caltech and operates in Brea, as highlighted by the Business Journal.
- MarketBeat featured Danaher, Moderna, and Vertex Pharmaceuticals in its stock screener.
- Financial news reports include HSBC cutting price targets on Danaher shares and corporate transactions involving Masimo.
- Danaher Corporation has filed required reports with the SEC, and Morgan Stanley has provided advice regarding price targets.
- Danaher Corporation filed ownership data with the SEC.
- Danaher Corporation is involved in the analyst rating services market alongside Jefferies Financial Group.
- Leica Biosystems is a company of Danaher Corporation.
- Life sciences companies Danaher Corporation and Twist Bioscience are facing headwinds due to exposure to China and academic spending.
- Norges Bank bought a new position in Danaher Corporation on June 15, 2026.
- MarketBeat used its screener to highlight Danaher Corporation's stock on June 14, 2026.
- Danaher Corporation filed disclosures with the SEC and DZ Bank began covering its shares.
- Danaher Corporation benefits from positive trends in China, while Wells Fargo cut its price target following quarterly results, influenced by Trump-era tariffs.
- The IVD market in India is driven by NCDs, with key companies like Roche, Sysmex, Danaher, Qiagen, and Quidel leading innovation-driven growth.
- Market growth and trade activity involving major companies like Abbott, Roche, Siemens, and Danaher in Africa.
- Trump pledged to unleash American oil and gas, while Steven Rales reported selling $246m worth of Danaher shares on August 5, 2025.
- A market report profiled key companies in the oligonucleotide synthesis market, including Danaher, Biogen, AstraZeneca, and others.
- Jim Cramer expressed sustained pessimism regarding Danaher Corporation's investment potential.
- Greg was appointed Executive Vice President at Danaher on June 27, 2025, overseeing companies including Beckman Coulter, Genedata, and Leica Microsystems, and joining via the acquisition of Molecular Devices.
- Danaher Corporation is noted to benefit from Trump-era tariffs, a point recently highlighted by Jim Cramer.
- Danaher Corporation reported increased demand for consumables from large pharmaceutical customers in Europe and Southeast Asia.
- The biopharmaceuticals manufacturing consumables testing market is growing, driven by demand for validated products, while US tariffs are simultaneously escalating costs for critical testing consumables.
- Danaher Corporation and AstraZeneca formed a partnership to scale precision medicine.
- Scotiabank analysts and TipRanks show strong buy consensus for life science tools, including Danaher Corporation.
- Leadership changes at Danaher Corporation, including Matthew McGrew's retirement, Gugino's transition to CFO, and Rainer Blair becoming President and CEO.
- Danaher Corporation reported its segment revenues for the Life Sciences, Diagnostics, and Biotechnology divisions on July 22, 2025.
- Danaher's stock is analyzed using momentum investing principles.
- LabCorp and Quest Diagnostics are notable players in the market alongside Danaher Corporation.
- Aldevron, a company owned by Danaher, is expanding into the Boston biotech corridor.
- Danaher acquired companies including Cepheid and Cytiva during a corporate transformation, appointing individuals like Jonathan Leiken and Brian Ellis to key roles.
- Veralto Corporation, which spun off from Danaher in 2023, operates globally and includes PQI in its segments.
- Zacks Investment Research provided stock analysis and recommendations for Danaher Corporation on August 18, 2025.
- Danaher's fund performance was compared against the S&P 500 Index on August 22, 2025.
- Danaher Corporation expanded its Life Sciences segment through an acquisition, coinciding with increased demand for consumables in Europe.
- Envista Holdings Corporation was formed as a wholly-owned subsidiary of Danaher Corporation on August 26, 2025.
- Danaher Corporation is headquartered in the District of Columbia and markets products across the United States.
- Danaher, Thermo Fisher Scientific, and Agilent Technologies are focused on dominating the global PFAS Testing market.
- Danaher Corporation provides bioprocess technologies and manufacturing services while Q32 Bio Inc. develops biologic therapeutics for autoimmune diseases.